Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer.
Int J Biol Macromol
; 245: 125510, 2023 Aug 01.
Article
in En
| MEDLINE
| ID: mdl-37353120
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Nanoparticles
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Int J Biol Macromol
Year:
2023
Document type:
Article
Affiliation country:
Taiwán
Country of publication:
Países Bajos